Susquehanna International Group
NDRAW

Susquehanna International Group’s ENDRA Life Sciences Inc. Warrants NDRAW Stock Holding History

Susquehanna International Group’s Portfolio NDRAW Stock Details NDRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-33,319
Closed -$3K – 14494
2021
Q4 		$3K Buy
+33,319
New +$7.64K ﹤0.01% 13006
2020
Q3 		– Sell
-35,297
Closed -$6K – 11398
2020
Q2 		$6K Buy
35,297
+24,908
+240% +$4.24K ﹤0.01% 10003
2020
Q1 		$2K Buy
+10,389
New +$3.48K ﹤0.01% 10130

Susquehanna International Group's NDRAW Position: Q1 2022 in Review

Susquehanna International Group sold out of ENDRA Life Sciences Inc. Warrants (NDRAW) in Q1 2022, closing a stake of 33,319 shares — an estimated $3K sold.

Susquehanna International Group first reported a position in NDRAW in Q1 2020 and held it in 3 quarters. The position peaked at $6K in Q2 2020. 1 fund tracked by Wall St. Rank holds NDRAW as of Q1 2022.

  • Susquehanna International Group reported no remaining ENDRA Life Sciences Inc. Warrants position as of Q1 2022 after selling out during the quarter.
  • Susquehanna International Group sold 33,319 ENDRA Life Sciences Inc. Warrants shares in Q1 2022, an estimated $3K.
  • Susquehanna International Group first reported a position in ENDRA Life Sciences Inc. Warrants in Q1 2020 and held it in 3 quarters.
  • Susquehanna International Group's ENDRA Life Sciences Inc. Warrants position peaked at $6K in Q2 2020.
  • 1 fund tracked by Wall St. Rank held ENDRA Life Sciences Inc. Warrants as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.